China Overseas Development (00688) announced interim results. Profit attributable to shareholders of about 7.03 billion yuan decreased by 18.24% year on year, with 23 HK cents per share

According to the Zhitong Finance App, China Overseas Development (00688) announced its 2026 interim results, with revenue of approximately $97.6 billion, up 17.28% year on year; profit attributable to the company's shareholders was approximately $7.03 billion, a year-on-year decrease of 18.24%; profit per share was 0.64 yuan, with an interim dividend of HK$23 cents per share.

During the period, the Group added 9 new land plots in 8 cities in mainland China and Hong Kong, China. The total land reserve construction area was 760,000 square meters, the equity construction area was 740,000 square meters, the total land price was RMB 7.86 billion, and the equity land price was RMB 7.66 billion.

During the period, the group's affiliated companies achieved contract sales of RMB 134.35 billion, an increase of 11.8% over the previous year. Revenue from commercial operations was RMB 3.58 billion. During the period, the CNOOC Health Beijing Jinchen Project opened, a benchmark product for the Group to explore new health care models and expand business in the Yinfa economic wave.

On June 30, 2026, the Group's balance ratio was 51.6%, and the net loan ratio was 27.2%. The amount of interest-bearing debt decreased by RMB 10.15 billion compared to the beginning of the year, and the net operating cash inflow was RMB 28.52 billion.